LATEST NEWS IN PROSTATE CANCER PCRI 12/2/20 PCRI 12/2/20 Press Release: Lantheus Holdings Submits New Drug Application to the U.S. FDA for PyLTM (18F-DCFPyL), a PSMA-Targeted Prostate Cancer Imaging Agent Read More PCRI 11/18/20 PCRI 11/18/20 NASPCC Webinar Series Presents: “Theranostics in Prostate Cancer" Read More PCRI 11/18/20 PCRI 11/18/20 NASPCC Webinar Series Presents: “Incontinence and Sexual Side Effects of Prostate Cancer Treatment” Read More PCRI 11/5/20 PCRI 11/5/20 National Alliance of State Prostate Cancer Coalitions Presents: "The PROCEED Registry and Disparities Work in Metastatic Prostate Cancer" Read More PCRI 11/5/20 PCRI 11/5/20 Active Surveillance & Beyond: A Webinar Series by UsToo and AnswerCancer: "The Value of mpMRI in Monitoring Men on Active Surveillance" Read More PCRI 10/22/20 PCRI 10/22/20 Prostate Cancer Support Association of New Mexico Presents its 2020 Annual (Virtual) Conference, "Your Path" Read More PCRI 9/16/20 PCRI 9/16/20 Active Surveillance & Beyond: A Free Webinar Series by UsToo and AnswerCancer Read More PCRI 9/10/20 PCRI 9/10/20 Press Release: New England Journal of Medicine Publishes Final Data for NUBEQA Plus Androgen Deprivation Therapy Showing a Statistically Significant Improvement in Overall Survival in Men with nmCRPC Read More PCRI 8/28/20 PCRI 8/28/20 Press Release: FDA Approves FoundationOne Liquid CDx To Serve As Rucaparib Companion Diagnostic To Identify Eligible Patients With BRCA1/2-Mutant, Metastatic Castration-Resistant Prostate Cancer Read More PCRI 8/28/20 PCRI 8/28/20 Press Release: Food and Drug Administration (FDA) Approves FoundationOne Liquid Biopsy Read More Newer Posts Older Posts
PCRI 12/2/20 PCRI 12/2/20 Press Release: Lantheus Holdings Submits New Drug Application to the U.S. FDA for PyLTM (18F-DCFPyL), a PSMA-Targeted Prostate Cancer Imaging Agent Read More
PCRI 11/18/20 PCRI 11/18/20 NASPCC Webinar Series Presents: “Theranostics in Prostate Cancer" Read More
PCRI 11/18/20 PCRI 11/18/20 NASPCC Webinar Series Presents: “Incontinence and Sexual Side Effects of Prostate Cancer Treatment” Read More
PCRI 11/5/20 PCRI 11/5/20 National Alliance of State Prostate Cancer Coalitions Presents: "The PROCEED Registry and Disparities Work in Metastatic Prostate Cancer" Read More
PCRI 11/5/20 PCRI 11/5/20 Active Surveillance & Beyond: A Webinar Series by UsToo and AnswerCancer: "The Value of mpMRI in Monitoring Men on Active Surveillance" Read More
PCRI 10/22/20 PCRI 10/22/20 Prostate Cancer Support Association of New Mexico Presents its 2020 Annual (Virtual) Conference, "Your Path" Read More
PCRI 9/16/20 PCRI 9/16/20 Active Surveillance & Beyond: A Free Webinar Series by UsToo and AnswerCancer Read More
PCRI 9/10/20 PCRI 9/10/20 Press Release: New England Journal of Medicine Publishes Final Data for NUBEQA Plus Androgen Deprivation Therapy Showing a Statistically Significant Improvement in Overall Survival in Men with nmCRPC Read More
PCRI 8/28/20 PCRI 8/28/20 Press Release: FDA Approves FoundationOne Liquid CDx To Serve As Rucaparib Companion Diagnostic To Identify Eligible Patients With BRCA1/2-Mutant, Metastatic Castration-Resistant Prostate Cancer Read More
PCRI 8/28/20 PCRI 8/28/20 Press Release: Food and Drug Administration (FDA) Approves FoundationOne Liquid Biopsy Read More
